Effect of medical and surgical interventions on health‐related quality of life in Parkinson's disease
- 24 April 2007
- journal article
- review article
- Published by Wiley in Movement Disorders
- Vol. 22 (6) , 757-765
- https://doi.org/10.1002/mds.21407
Abstract
Motor‐related parameters are the standard outcome parameters for treatment interventions. Nonetheless, subjective appraisals about the consequences of treatment on health‐related quality of life (HRQoL) are meanwhile established and may uncover important aspects of interventions. We have reviewed the literature with a defined search strategy and collected 61 clinical trials, which have used HRQoL as a planned outcome parameter. The articles were rated similarly as for the Task Force report of the Movement Disorder Society on interventions for Parkinson's disease (PD), but the relevant outcome parameter was HRQoL. We found that unilateral pallidotomy, deep brain stimulation of the subthalamic nucleus, and rasagiline are efficacious to improve the HRQoL of PD patients. For many other interventions, the efficacy to improve HRQoL in the PD setting cannot be considered to be proven so far. HRQoL should be part of future trial designs and more research is necessary to understand the determinants of QoL in PD. © 2007 Movement Disorder SocietyKeywords
This publication has 77 references indexed in Scilit:
- Efficacy of combining levodopa with entacapone on quality of life and activities of daily living in patients experiencing wearing-off type fluctuationsActa Neurologica Scandinavica, 2005
- An open-label evaluation of the tolerability and safety of Stalevo® (carbidopa, levodopa and entacapone) in Parkinson’s disease patients experiencing wearing-offJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2004
- Improvement in quality of life in patients with advanced Parkinson's disease following bilateral deep‐brain stimulation in subthalamic nucleusEuropean Journal of Neurology, 2004
- Combining entacapone with levodopa/DDCI improves clinical status and quality of life in Parkinson?s Disease (PD) patients experiencing wearing-off, regardless of the dosing frequency: results of a large multicentre open-label studyJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2004
- A waitlist control-group study of cognitive, mood, and quality of life outcome after posteroventral pallidotomy in Parkinson diseaseJournal of Neurosurgery, 2003
- Neuropsychological and Quality of Life Changes Following Unilateral Thalamic Deep Brain Stimulation in Parkinson's Disease: A One-Year Follow-upActa Neurochirurgica, 2001
- Outcome of unilateral pallidotomy in advanced Parkinson's disease: cohort study of 32 patientsJournal of Neurology, Neurosurgery & Psychiatry, 2001
- Randomized trial of tolcapone versus pergolide as add‐on to levodopa therapy in Parkinson's disease patients with motor fluctuationsMovement Disorders, 2001
- Unilateral pallidotomy in Parkinson's disease: a randomised, single-blind, multicentre trialThe Lancet, 1999
- Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patientsJournal of Neurology, Neurosurgery & Psychiatry, 1997